These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. ABO-Incompatible Living Donor Liver Transplantation With a Simplified Desensitization and Immunosuppression Protocol: A Single-Center Retrospective Study. Lee TB; Ko HJ; Shim JR; Choi BH; Ryu JH; Yang K Exp Clin Transplant; 2021 Jul; 19(7):676-685. PubMed ID: 34325624 [TBL] [Abstract][Full Text] [Related]
24. Anti-IL-2R blockers comparing with polyclonal antibodies: Higher risk of rejection without negative mid-term outcomes after ABO-incompatible kidney transplantation. Del Bello A; Divard G; Belliere J; Congy-Jolivet N; Lanfranco L; Ricard R; Delas A; Colombat M; Esposito L; Hebral AL; Cointault O; Lefaucheur C; Loupy A; Kamar N Clin Transplant; 2019 Oct; 33(10):e13681. PubMed ID: 31369170 [TBL] [Abstract][Full Text] [Related]
25. One-year protocol biopsies from ABO-incompatible renal allografts compared with a matched cohort of ABO-compatible allografts. Dörje C; Mjøen G; Strøm EH; Holdaas H; Jenssen T; Øyen O; Akkök ÇA; Cvancarova M; Midtvedt K; Reisaeter AV Clin Transplant; 2015 Mar; 29(3):268-76. PubMed ID: 25644963 [TBL] [Abstract][Full Text] [Related]
26. Favorable results in ABO-incompatible renal transplantation without B cell-targeted therapy: Advantages and disadvantages of rituximab pretreatment. Okada M; Watarai Y; Iwasaki K; Murotani K; Futamura K; Yamamoto T; Hiramitsu T; Tsujita M; Goto N; Narumi S; Takeda A; Morozumi K; Uchida K; Kobayashi T Clin Transplant; 2017 Oct; 31(10):. PubMed ID: 28792635 [TBL] [Abstract][Full Text] [Related]
27. Lower incidence of de novo donor-specific antibodies against HLA-DR in ABO-incompatible renal transplantation. Okada M; Watarai Y; Iwasaki K; Futamura K; Yamamoto T; Hiramitsu T; Tsujita M; Goto N; Narumi S; Takeda A; Kobayashi T Hum Immunol; 2019 Mar; 80(3):169-175. PubMed ID: 30552908 [TBL] [Abstract][Full Text] [Related]
28. ABO-incompatible kidney transplantation in perspective of deceased donor transplantation and induction strategies: a propensity-matched analysis. de Weerd AE; van den Brand JAJG; Bouwsma H; de Vries APJ; Dooper IPMM; Sanders JF; Christiaans MHL; van Reekum FE; van Zuilen AD; Bemelman FJ; Nurmohamed AS; van Agteren M; Betjes MGH; de Jong MFC; Baas MC Transpl Int; 2021 Dec; 34(12):2706-2719. PubMed ID: 34687095 [TBL] [Abstract][Full Text] [Related]
29. ABO-Incompatible Living Donor Liver Transplant From a Blood Type A2 Donor to a Type B Recipient: A Note of Caution. Puri Y; Rammohan A; Sachan D; Vij M; Rela M Exp Clin Transplant; 2022 Jan; 20(1):100-103. PubMed ID: 34763633 [TBL] [Abstract][Full Text] [Related]
30. Transplantation of ABO-incompatible and living unrelated donor-recipient combinations. Ishikawa N; Yagisawa T; Sakuma Y; Fujiwara T; Nukui A; Yashi M; Miyamoto N Transplant Proc; 2008 Sep; 40(7):2292-3. PubMed ID: 18790215 [TBL] [Abstract][Full Text] [Related]
31. Long-term Outcomes of ABO-Incompatible Living Donor Kidney Transplantation: A Comparative Analysis. Shin E; Kwon SW; Yang WS; Baeck C; Yu H; Cho H; Park SK Transplant Proc; 2015; 47(6):1720-6. PubMed ID: 26293040 [TBL] [Abstract][Full Text] [Related]
33. Once-daily vs twice-daily tacrolimus for de novo living kidney transplantation patients including ABO/HLA compatible and incompatible: A randomized trial. Okumi M; Unagami K; Furusawa M; Kakuta Y; IIzuka J; Takagi T; Shirakawa H; Shimizu T; Omoto K; Inui M; Ishida H; Tanabe K Clin Transplant; 2018 Dec; 32(12):e13423. PubMed ID: 30318624 [TBL] [Abstract][Full Text] [Related]
34. Efficacy of 2 Doses of Rituximab on B-Cell and Antidonor Antibody and Outcomes of ABO-Incompatible Living-Donor Pediatric Kidney Transplant. Hamasaki Y; Aikawa A; Itabashi Y; Muramatsu M; Hyoudou Y; Shinoda K; Takahashi Y; Sakurabayashi K; Mizutani T; Oguchi H; Kawamura T; Sakai K; Shishido S Exp Clin Transplant; 2019 Jan; 17(Suppl 1):105-109. PubMed ID: 30777532 [TBL] [Abstract][Full Text] [Related]